Cue Health Inc. (HLTH)
Pre-Market:
| Previous Close | 0.0964 |
| Open | 0.1247 |
| Bid | 0.1000 x 100 |
| Ask | 0.1210 x 100 |
| Day's Range | 0.1052 - 0.1320 |
| 52 Week Range | 0.0900 - 0.8350 |
| Volume | |
| Avg. Volume | 2,858,214 |
| Market Cap | 18.789M |
| Beta (5Y Monthly) | 1.30 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)
SAN DIEGO, May 14, 2024--Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company (the "Company"), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-19 test. The Company is currently evaluating the letter and determining its response, with more information to follow in the next few days.
- Business Wire
Cue Health to Announce First Quarter Financial Results
SAN DIEGO, April 29, 2024--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Monday, May 13, 2024. The company will not be hosting a conference call.
- Business Wire
Cue Health Announces Strategic Actions to Position Company for Next Stage
SAN DIEGO, March 20, 2024--Cue Health Inc. ("Cue" or the "Company") (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the "Board") to best position the Company for its next stage:
